Last updated: October 12, 2022
Sponsor: University of Copenhagen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cerebral Ischemia
Low Blood Pressure (Hypotension)
Distal Renal Tubular Acidosis
Treatment
N/AClinical Study ID
NCT05582824
LacMeta
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosed with sepsis/septic shock or severe heart failure.
- Clinical and paraclinical signs of hypoperfusion in relation to abovementioneddiagnosis.
- Metabolic acidosis with s-lactate equal-to-or-above 4 mmol/l.
- Incapacitated
Exclusion
Exclusion Criteria:
- Only regional hypoperfusion such as a leg.
- Receiving intravenous lactate as part of treatment.
- Going in to dialysis. The exclusion is only during dialysis treatment.
Study Design
Total Participants: 20
Study Start date:
September 15, 2022
Estimated Completion Date:
January 31, 2023
Study Description
Connect with a study center
Hvidovre University Hospital
Hvidovre, Hovedstaden 2650
DenmarkActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.